by Steven Ertelt
November 19, 2004
Washington, DC (LifeNews.com) — Pro-life lawmakers in Congress will move forward with legislation to temporarily take the dangerous RU 486 abortion drug off the market so its safety can be thoroughly reviewed. They say they will begin their effort to pass such a bill when Congress reconvenes early next year.
Under the bill, the RU 486 abortion drug would be blocked from being sold while the Government Accountability Office, Congress’ investigative arm, conducts a six-month review of the drug, its safety, and approval process.
Congressman Jim DeMint, elected to become a U.S. senator from South Carolina, was the prime sponsor in the House. He said numerous questions remain about the FDA’s rushed approval process for the abortion pill, which was approved under protocol for drugs used to treat life-threatening conditions.
DeMint told the Washington Times that the approval process, conducted during the waning days of the Clinton administration was "thoroughly political, not scientific."
If the FDA was found to have violated its own rules, DeMint said, the drug could be prohibited indefinitely. If not, the suspension would be lifted.
Lisa Wright, secretary for pro-life Rep. Roscoe Bartlett of Maryland, another key House sponsor of the bill, confirmed that the legislation will be reintroduced in the next legislative session.
"It’s an unequivocal yes that we will reintroduce the bill," she told the Times.
Dr. Pia de Solenni of the Family Research Council says the bill is needed and applauded pro-life lawmakers for pushing it forward.
"This harmful and unethical drug was processed with a minimal amount of testing and short-circuited through the approval process due to political motivations. Kudos to Republican leadership in recognizing that RU-486 should be eliminated," de Solenni said.